近半个世纪仅研发获得三款新药，与拥挤的PD-1等抗肿瘤药赛道相比，抗结核药研发管线几近枯竭，新药可及性偏低，仿制药企积极性也不高，这是包括中国在内的结核高负担国家面临的公共健康挑战。

参考资料：

[1] TB Alliance: FDA approves new treatment for highlydrug-resistant forms of tuberculosis.

[2] FDA News Release: FDA approves new drug for treatment-resistantforms of tuberculosis that affects the lungs.

[3] MSF: New drug to fight deadliest form of TB mustbe made affordable.

[4] MSF response to Janssen’s bedaquiline donationannouncement.

[5] MSF: Johnson & Johnson should make TB drugavailable for all at $1/day.

[6] 国家药品监督管理局视频药品审核查验中心：FDA加快推出抗菌药耐药性问题解决的新方法。